Saturday, 17 October 2026European Markets

CORBION Stock Is 10% Down So Far On Friday

Loading stream...

(VIANEWS) - Shares of CORBION (AEX-Index: CRBN.AS) slid by a staggering 10.88% to €32.28 at 13:09 EST on Friday, after two sequential sessions in a row of gains. AEX-Index is jumping 0.53% to €759.17, after two successive sessions in a row of losses. This seems, up to now, a somewhat positive trend exchanging session today.

CORBION's last close was €36.22, 4.08% under its 52-week high of €37.76.

About CORBION

Corbion N.V. provides lactic acid and lactic acid derivatives, emulsifiers, functional enzyme blends, minerals, vitamins, and algae ingredients worldwide. The company offers ingredient solutions made from renewable resources for the food, home and personal care, pharmaceutical, animal nutrition, medical device, and bioplastics markets. It markets its products through a network of sales offices and distributors. The company was formerly known as CSM N.V. and changed its name to Corbion N.V. in October 2013. Corbion N.V. was founded in 1919 and is headquartered in Amsterdam, the Netherlands.

Earnings Per Share

As for profitability, CORBION has a trailing twelve months EPS of €1.06.

PE Ratio

CORBION has a trailing twelve months price to earnings ratio of 30.45. Meaning, the purchaser of the share is investing €30.45 for every euro of annual earnings.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 10.81%.

Volume

Today's last reported volume for CORBION is 512345 which is 974.14% above its average volume of 47698.

Volatility

CORBION's last week, last month's, and last quarter's current intraday variation average was a positive 0.86%, a negative 0.10%, and a positive 1.31%.

CORBION's highest amplitude of average volatility was 0.92% (last week), 1.11% (last month), and 1.31% (last quarter).

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, CORBION's stock is considered to be oversold (<=20).

More news about CORBION (CRBN.AS).

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Autumn 2026 Governance Reshuffle: CEO Successions, Activist Settlements and Corporate Separations
Across sectors, boards are replacing or rotating leadership (Bausch + Lomb's abrupt CEO exit, Keyser's move to advisor, Deputy CEO promotions, Brown-Forman and BellRing successions). At the same time, activist pressure is being settled through cooperation agreements and board seats (Stride/Fivespan, Al Shams) and through structural separations (National Fuel's IUG spin-out, NGEx). The common thread is boards using governance levers such as new committees, advisory seats and planned succession to reset capital allocation and strategy. Public messaging stresses continuity and partnership, but the number of interim appointments and activist-driven changes points to underlying pressure.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,384 source documents archived
Query this data → isubstrate.com